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Abstract 
The mechanisms of immune response to cancer have been studied extensively and great effort has 
been invested into harnessing the therapeutic potential of the immune system. Immunotherapies 
have seen significant advances in the past 20 years, but the full potential of protective and 
therapeutic cancer immunotherapies has yet to be fulfilled. The insufficient efficacy of existing 
treatments can be attributed to a number of biological and technical issues. In this review, we detail 
the current limitations of immunotherapy target selection and design, and review computational 
methods to streamline therapy target discovery in a bioinformatics analysis pipeline. We describe 
specialized bioinformatics tools and databases for three main bottlenecks in immunotherapy target 
discovery: the cataloging of potentially antigenic proteins, the identification of potential HLA 
binders, and the selection epitopes and co-targets for single-epitope and multi-epitope strategies. We 
provide examples of application to the well-known tumor antigen HER2 and suggest bioinformatics 
methods to ameliorate therapy resistance and ensure efficient and lasting control of tumors. 
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